Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Clinical trial NCT00219284 · COMPLETED

Trial details

NCT number: NCT00219284
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson's Disease With End of Dose Wearing Off

Start date: 2005-01-01
Primary completion: 2008-07-01
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.